3 terminated. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow Fibrosarcoma: new trials by email Literature Review of Fibrosarcoma trials Research Report on Fibrosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma doxorubicin hydrochloride, trabectedin, laboratory biomarker analysis - Sarcoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 133 | 2011-05-01 | 2014-08-08 |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer cyproheptadine hydrochloride, placebo - Cancer | Phase 3 | Terminated | University of South Florida | 22 | 2010-06-01 | 2015-07-02 |
| Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors imatinib mesylate - Malignant Peripheral Nerve Sheath Tumors | Phase 2 / Phase 3 | Terminated | Novartis Pharmaceuticals | 11 | 2006-05-01 | 2012-08-07 |
Hemangiosarcoma (2) · Neurofibrosarcoma (2) · Sarcoma (2) · Astrocytoma (1) · Body Weight Changes (1) · Bone Neoplasms (1) · Cachexia (1) · Chondrosarcoma (1) · Chondrosarcoma, Extraskeletal Myxoid (1) · Choroid Plexus Neoplasms (1) · Desmoplastic Small Round Cell Tumor (1) · Familial ependymoma (1) · Glioblastoma (1) · Hemangiopericytoma, Malignant (1)
Neoplasms by Histologic Type (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Fibrous Tissue (3) · Neoplasms, Nerve Tissue (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Peripheral Nervous System Neoplasms (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Neoplasms (2) · Neoplasms, Vascular Tissue (2) · Neoplastic Syndromes, Hereditary (2) · Neurofibroma (2) · Neuromuscular Diseases (2)
Cyproheptadine (1) · Doxorubicin (1) · Imatinib Mesylate (1) · Trabectedin (1)
European Organisation for Research and Treatment of Cancer - EORTC (1) · Novartis Pharmaceuticals (1) · University of South Florida (1)
Germany (2) · United States (2) · Austria (1) · Belgium (1) · Denmark (1) · France (1) · Hungary (1) · Netherlands (1) · Poland (1) · Slovakia (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
James E. Butrynski, MD (1) · Jeffrey P. Krischer, PhD (1) · Nguyen Binh Bui, MD (1)
2009 (1), U10CA081920 (1)